methylphenidate
Commercial- Indications
- Attention deficit hyperactivity disorder
Company intelligence / Profile preview
Rhodes Pharmaceuticals develops and distributes a broad portfolio of generic and branded pharmaceutical products with an emphasis on controlled substances such as opioids for pain management, stimulants for ADHD, buprenorphine for opioid addiction treatment, antidepressants, cholesterol medications, cannabinoids like dronabinol, and others. The company has over two dozen approved drugs in the U.S. market. It has faced scrutiny due to its role as a major manufacturer of opioids during the U.S. opioid crisis but continues to operate commercially with ongoing R&D efforts including new drug applications.[6][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhodes Pharmaceuticals.